Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigen binding protein and its use as addressing product for the treatment of cancer

Antigen binding protein and its use as addressing product for the treatment of cancer

US Patent 9689862 · Granted Jun 27, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer2022
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Composition for the treatment of IGF-1R expressing cancer2020
Composition for the treatment of IGF-1R expressing cancer2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2020
Antibody-drug-conjugate and its use for the treatment of cancer2019
Antibody-drug-conjugate and its use for the treatment of cancer2019